Cosmetic treatments – a new generation
New research from LaingBuisson suggests that demand for cosmetic surgery has softened since the global economic crisis and PIP scandal but non-surgical treatments are...
Can pharma innovate like a tech giant?
When it comes to digital disruption in healthcare, oncology, perhaps more than any other specialty, is changing the most. Dr Michelle Tempest and Roma...
Opportunities in oncology
IDF CEO Sue Smith, along with President John O’Connor and Professor John Crown, discuss the impact of new cancer treatments
There is never a good...
Paying your way
As NHS work declines, major hospital operators are increasingly looking to take advantage of the uplift in self-pay by offering easy payment options. Anna...
Adapt or die
Independent healthcare is facing unprecedented challenges as the fall-out from Paterson and the CQC report continue, the NHS reins in spending and Brexit casts...
The paperless referral
From the start of this month, acute providers will no longer be paid for any first outpatient appointment that hasn’t been made electronically. NHS...
PHIN – moving between phases
Anna Cole-Bailey, spoke to PHIN chief executive Matt James about the organisation’s progress so far; a mood change in the private sector and the...
The eyes have it
Dr Michelle Tempest and Patrick Bansch of bespoke health and social care strategy and investment consultancy Candesic get a close-up look of the private...
Clearing the mist on cataract surgery
With demand for cataract surgery on the rise, it is little wonder that some CCGs are looking to restrict access by introducing ‘visual acuity’...
The DOLLAR$ in DIALYSIS
The dialysis market is highly consolidated but is there room for growth? Sam Coates, Gonçalo Silva and Dr Victor Chua of Mansfield Advisors assess...
©2024 All rights reserved LaingBuisson 